These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11427661)

  • 1. Fibrate-induced increase in blood urea and creatinine.
    Lipscombe J; Bargman JM
    Nephrol Dial Transplant; 2001 Jul; 16(7):1515. PubMed ID: 11427661
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrate treatment can increase serum creatinine levels.
    Tsimihodimos V; Kakafika A; Elisaf M
    Nephrol Dial Transplant; 2001 Jun; 16(6):1301. PubMed ID: 11390746
    [No Abstract]   [Full Text] [Related]  

  • 3. Creatinine rise after fibrate therapy in renal graft recipients.
    Devuyst O; Goffin E; Pirson Y; van Ypersele de Strihou C
    Lancet; 1993 Mar; 341(8848):840. PubMed ID: 8096050
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?
    Broeders N; Knoop C; Antoine M; Tielemans C; Abramowicz D
    Nephrol Dial Transplant; 2000 Dec; 15(12):1993-9. PubMed ID: 11096145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrates and renal function.
    Gajdos M; Dzúrik R
    Clin Nephrol; 2003 Jul; 60(1):65-6. PubMed ID: 12872864
    [No Abstract]   [Full Text] [Related]  

  • 6. [Does hypothyroidism potentialize muscular toxicity of fibrates?].
    Harlé JR; Toussirot E; Disdier P; Drancourt M; Weiller PJ
    Rev Med Interne; 1990; 11(4):336. PubMed ID: 2096444
    [No Abstract]   [Full Text] [Related]  

  • 7. Abnormal lipid profiles on fibrate derivatives.
    McLeod AJ; Warren RJ; Armitage M
    Lancet; 1996 Jan; 347(8996):261. PubMed ID: 8551900
    [No Abstract]   [Full Text] [Related]  

  • 8. Transitory deficit in high-density lipoproteins and apolipoprotein A-I.
    Legras B; Clerc C; Ruelland A; Doualin G; Fertil V; Cloarec L
    Clin Chem; 1990 Mar; 36(3):580-1. PubMed ID: 2107044
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute renal failure due to rhabdomyolysis in presence of concurrent ciprofibrate and ibuprofen treatment.
    Ramachandran S; Giles PD; Hartland A
    BMJ; 1997 May; 314(7094):1593. PubMed ID: 9186171
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of various fibrates on serum alkaline phosphatase activity.
    Ganotakis E; Tsimihodimos V; Bairaktari E; Rizos E; Athyros V; Seferiades C; Elisaf M
    Atherosclerosis; 2002 Nov; 165(1):187-8. PubMed ID: 12208487
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrate monotherapy and profound hypoalphalipoproteinaemia.
    Olukoga AO; Crowley VE; Stewart MF; Weinkove O
    Postgrad Med J; 1996 Mar; 72(845):189. PubMed ID: 8731722
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid profiles on fibric-acid derivatives.
    Capps NE
    Lancet; 1994 Sep; 344(8923):684-5. PubMed ID: 7915370
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-specific toxicity of fibrates in human embryonal rhabdomyosarcoma cells.
    Maiguma T; Fujisaki K; Itoh Y; Makino K; Teshima D; Takahashi-Yanaga F; Sasaguri T; Oishi R
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):289-96. PubMed ID: 12644902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenofibrate-Induced elevation in serum creatinine.
    Ritter JL; Nabulsi S
    Pharmacotherapy; 2001 Sep; 21(9):1145-9. PubMed ID: 11560205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrate-induced increase in serum creatinine levels: two cases].
    Décaudin B; Beraud G; Lannoy D; Semjen E; Wierre L; Horrent S; Résibois JP; Azar R; Odou P
    Therapie; 2005; 60(6):601-2. PubMed ID: 16555504
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe rhabdomyolysis during a hypersensitivity reaction to abacavir in a patient treated with ciprofibrate.
    Fontaine C; Guiard-Schmid JB; Slama L; Essid A; Lukiana T; Rondeau E; Pialoux G
    AIDS; 2005 Nov; 19(16):1927-8. PubMed ID: 16227807
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ciprofibrate-induced acute cholestatic hepatitis].
    Pflumio F; Andrès E; Ubrich M; Geisler F; Imbs JL; Di Liberatore M
    Ann Endocrinol (Paris); 2003 Jun; 64(3):232-3. PubMed ID: 12910067
    [No Abstract]   [Full Text] [Related]  

  • 18. False estimates of elevated creatinine.
    Samra M; Abcar AC
    Perm J; 2012; 16(2):51-2. PubMed ID: 22745616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does hypothyroidism predispose muscular toxicity of fibrates?].
    Tregouet B
    Rev Med Interne; 1991; 12(2):159. PubMed ID: 1853004
    [No Abstract]   [Full Text] [Related]  

  • 20. Ciprofibrate and lipid profile.
    McLeod AJ; Warren RJ; Armitage M
    Lancet; 1994 Oct; 344(8927):955. PubMed ID: 7934365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.